Soluble cd46 as a diagnostic marker of hepatic steatosis

HIGHLIGHTS

• What: Study approval and patient cohorts Here, the authors report outcomes from two independent cohorts of patients recruited and treated at University Hospital Regensburg in Germany (Fig 1). For the training sets, the authors report the performances recalculating the ROC curve on the bootstrap.
• Who: Florian Bitterer from the Department of Surgery, University Hospital Regensburg, Regensburg, Germany have published the Article: Soluble CD46 as a diagnostic marker of hepatic steatosis, in the Journal: (JOURNAL)
• How: Data were collected with a Navios or CytoFlex LX cytometer and were analysed with Kaluza 2.1 (all . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.